Butterfly Network to Host Investor Day on Monday, March 18, 2024, at the New York Stock Exchange
22 Febrero 2024 - 7:00AM
Business Wire
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital
health company transforming care with handheld, whole-body
ultrasound, today announced that it will host an Investor Day on
Monday March 18, 2024, beginning at 12:00pm ET at the New York
Stock Exchange.
During the event, Butterfly’s executive management team will
present the Company’s product, software and services portfolio
within the point-of-care ultrasound landscape, as well as its
strategic initiatives, technology roadmap, and overarching vision.
The agenda will include live demonstrations of products, including
the newly released, next-generation Butterfly iQ3™.
Speakers will include:
- President, Chief Executive Officer & Chairman Joseph
DeVivo
- Chief Financial & Operations Officer, Heather Getz
- Chief Medical Officer, John Martin, MD
- Chief Technology Officer, Andrei Stoica, PhD
- Chief Strategy Officer, Darius Shahida
- Senior Vice President of Home Care, Paula LeClair
- Senior Director of Global Health, Sachita Shah, MD
Butterfly will also be joined by strategic partners introducing
AI tools and novel products that are in co-development.
Attendance at the event will be reserved for analysts and
institutional investors. To inquire about attendance at the event,
please reach out to nnagarajan@sloanepr.com and
keskwitt@sloanepr.com.
A copy of the presentation materials and replay of the event
will be available following the event on Butterfly’s Events &
Presentations page on the investor relations website.
About Butterfly Network
Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network is a
digital health company with a mission is to democratize medical
imaging by making high-quality ultrasound affordable, easy-to-use,
globally accessible, and intelligently connected, including for the
4.7 billion people around the world lacking access to ultrasound.
Butterfly created the world's first handheld single-probe,
whole-body ultrasound system using semiconductor technology,
Butterfly iQ. The company has continued to innovate, leveraging the
benefits of Moore’s Law, to launch its second generation Butterfly
iQ+ in 2020, and third generation iQ3 in 2024 – each with increased
processing power and performance enhancements. The disruptive
technology has been recognized by TIME’s Best Inventions, Fast
Company’s World Changing Ideas, CNBC Disruptor 50, and MedTech
Breakthrough Awards, among other accolades. With its proprietary
Ultrasound-on-Chip™ technology, intelligent software, and
educational offerings, Butterfly is paving the way to mass adoption
of ultrasound for earlier detection and remote management of health
conditions around the world. Butterfly devices are commercially
available to trained healthcare practitioners in areas including,
but not limited to, parts of Africa, Asia, Australia, Europe, the
Middle East, North America and South America; to learn more about
available countries, visit:
https://www.butterflynetwork.com/choose-your-country.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240221859448/en/
Butterfly Media:
Liz Learned Head of Corporate Communications, Butterfly
media@butterflynetwork.com
Butterfly Investors:
Heather Getz Chief Financial and Operations Officers, Butterfly
investors@butterflynetwork.com
or
Neal Nagarajan IR Agency Representative, Sloane & Company
(301) 273-5662 nnagarajan@sloanepr.com
Butterfly Network (NYSE:BFLY)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
Butterfly Network (NYSE:BFLY)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024